It’s always better to prevent a disease than to treat it. Vaccine prevent disease in the people who receive them. If enough people are vaccinated against a disease, then the disease cannot spread into their community. This is known as “Community Immunity.”

How do Vaccines Protect from Diseases?

When our immune system recognizes germs that enter the body as “foreign” invaders, or antigens it works not only to clear your body of that invader, but also creates a large number of memory cells that are specifically tuned to react to it. This protection is called immunity. Vaccines contain little bits of a disease – broken down and harless, and when injected, stimulate the production of antibodies. Through vaccination, we develop immunity without suffering from the actual diseases that vaccines prevent.

The Burden of Influenza

  • $24.6 billion in economic costs per year in the U.S. related to influenza and pneumonia

New vaccinations for emerging diseases and for infections that have been prevalent in the past offer hope for a healthier future for all.

What can I do?

RCR is currently seeking healthy volunteers for several investigational vaccine research studies. If you are over the age of 18, you could participate in one of the following investigational vaccine studies:

Dengue Fever Vaccine Study

Rochester Clinical Research is currently seeking participants between the ages of 18-50 years old to participate in a Dengue Fever vaccine study. The study is 1 year long and consists of 8 visits to our office. You will be compensated up to $150 per visit for your time and travel to participate.

View Trial Details
Ages 18 – 50
Compensation* $150 per visit
Study Topics Dengue Fever

*Compensation for time and travel may be available to those who qualify.

Flu Vaccine Study

Rochester Clinical Research is looking for volunteers 65 years or older to participate in a flu vaccine research study. The study is approximately 12 months long and consists of 5 to 7 visits to our office. You will be compensated $165 per visit for your time and travel to participate.

View Trial Details
Ages 65+
Compensation* $165 Per Visit
Study Topics Vaccines

*Compensation for time and travel may be available to those who qualify.

Varicella Vaccine Study

Rochester Clinical Research is currently looking for individuals to join a vaccine study for the varicella-zoster virus. Varicella is one of nine in the herpes class that can infect humans and causes chickenpox or shingles infections when it’s not prevented. The purpose of this study is to evaluate the safety and effectiveness of an mRNA vaccine against the virus. We are seeking participants between the ages of 50-69 years old who have not received a shingles vaccine already. This study is between 8-12 months long and includes at least 10 office visits. Compensation is available for $128 per office visit.

View Trial Details
Ages 50 – 69
Compensation* $128 per visit and $5 per diary entry
Study Topics Vaccines

*Compensation for time and travel may be available to those who qualify.

Featured

CMV Adolescents Vaccine Study

Rochester Clinical Research is currently seeking volunteers between the ages of 9-25 years old to participate in a preventative CMV vaccine study. The purpose of this study is to vaccinate children against the virus to prevent them from spreading it to adults, especially women that may be planning on becoming pregnant in the foreseeable future. The study is approximately 18 months long and includes 12 visits in total.

View Trial Details
Ages 9 – 25
Compensation* $1,809
Study Topics Vaccines

*Compensation for time and travel may be available to those who qualify.

Featured

Pediatric Lyme Disease Vaccine Study

There is currently no vaccine to prevent or protect against Lyme. RCR is currently conducting a vaccine study to help prevent Lyme disease from infecting adolescents between the ages of 5 to 17. This study will last approximately 24 months with 6 visits to our RCR office and 2 telephone calls. 

View Trial Details
Ages 5 – 17
Compensation* $125 per visit
Study Topics Vaccines

*Compensation for time and travel may be available to those who qualify.

RSV Vaccine Study

Rochester Clinical Research is currently seeking volunteers ages 50-59 years of age, who are at risk for chronic asthma/COPD, cardiovascular health hx, stroke/HA, and diabetes, to participate in an RSV (respiratory syncytial virus) vaccine study. This paid research study is testing the immune response and safety of a phase 3 vaccine. The study is about 12 months long and requires 4 visits to our office. If you qualify, you may be compensated for your time and travel to participate in the study.

View Trial Details
Ages 50 – 59
Compensation* TBD
Study Topics Vaccines

*Compensation for time and travel may be available to those who qualify.

Flu Vaccine Trial

Rochester Clinical Research is currently seeking volunteers who are 65 years and older for an Influenza vaccine study. The purpose of this study will be to evaluate the safety and immunogenicity of an mRNA vaccine to prevent influenza. Compensation for time and travel is available for around $630 to those who qualify.

View Trial Details
Ages 65+
Compensation* Around $500
Study Topics Vaccines

*Compensation for time and travel may be available to those who qualify.

Featured

mRNA Flu Vaccine Study

Rochester Clinical Research is seeking volunteers who are 65 years and older to participate in an investigational mRNA flu vaccine study. The purpose of this study is to evaluate the effectiveness of using mRNA technology in an investigational flu vaccine and see if it protects against different variants. This is a phase 3 study and is about 12 months long with only one visit to our office.

View Trial Details
Ages 65+
Compensation* $834
Study Topics Vaccines

*Compensation for time and travel may be available to those who qualify.

Featured

CMV Vaccine

Rochester Clinical Research is currently seeking born-female volunteers between the ages of 16 and 40 years old to participate in a CMV vaccine study. The purpose of this study is to find a safe and effective vaccine against Cytomegalovirus.

View Trial Details
Ages 16 – 40
Gender For female patients only
Study Topics Vaccine